Challenge Area of Personalized Drug Response and Toxicity Challenge Topic: 04-GM-101 A.
Specific aims I t is well established that drug toxicity varied individually. Although some genetic loci have been identified, most of the genetic factors remain to be elusive. Until now, the genetic factors identified are involved in either drug metabolism or in direct toxicity to the target cells. More recently, we identified CD24-Siglec10/G interaction as a key regulator for host response to necrosis induced by acetaminophen, which is (Science. 2009 Mar 5. [Epub ahead of print]PMID: 19264983)the drug that is associated with the most of the drug overdose-induced hospitalization in the West. Based on our extensive studies on CD24 association with multiple autoimmune disease in humans (PNAS 100(25):15041-6;PLOS Genetics, 2007 Apr 6;3(4):e49), we propose here to test if the only known coding CD24 polymorphism would affect host response to acetaminophen by comparing mice with knockin of the two alleles of human CD24 for their resistance to the acetaminophen. In addition, we will develop a genetic model to determine whether the drug resistancy conveyed by CD24 is due to its regulation of production of inflammatory cytokine by hematopoietic cells, especially dendritic cells, either using a lineage-specific deletion of the CD24 gene, generation of bone marrow chimera or transgenic mice expressing CD24 exclusively on CD11c+ cells. Our proposed studies may potentially identify an important genetic marker for personalized drug resistance and elucidate cellular mechanism by which CD24 regulates drug toxicity. This proposal responds to 04-GM-101*, personalized drug response and toxicity. The proposed studies will be carried out by two new postdoctoral researchers and a technician. The studies can be completed within 2 years.

Public Health Relevance

It is well established that drug toxicity varied individually. We recently identified CD24-Siglec10/G interaction as a key regulator for host response to liver necrosis induced by acetaminophen (Science. 323:1722 2009). Previous research has estimated that there are 60,000 cases of acetaminophen overdose annually, most of which are suicide attempts. Nearly 26,000 are hospitalized each year. Based on our extensive studies on CD24 association with multiple autoimmune disease in humans (PNAS 100:15041, 2003;PLoS Genetics 3:e49, 2007), we propose here to test if the only known coding CD24 polymorphism would affect host response to acetaminophen. We will compare mice with knockin of the two alleles of human CD24 for their resistance to the acetaminophen. We will develop a genetic model to determine whether the drug resistance conveyed by CD24 is due to its regulation of production of inflammatory cytokine by dendritic cells. Our proposed studies may potentially identify an important genetic marker for personalized drug resistance and elucidate cellular mechanism by which CD24 regulates drug toxicity. This proposal responds to 04-GM-101*, personalized drug response and toxicity.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
NIH Challenge Grants and Partnerships Program (RC1)
Project #
5RC1GM091648-02
Application #
7937899
Study Section
Special Emphasis Panel (ZRG1-DKUS-A (58))
Program Officer
Long, Rochelle M
Project Start
2009-09-30
Project End
2012-02-29
Budget Start
2010-09-01
Budget End
2012-02-29
Support Year
2
Fiscal Year
2010
Total Cost
$498,910
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Surgery
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Chen, Weilin; Han, Chaofeng; Xie, Bin et al. (2013) Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 152:467-78
Tang, Fei; Wu, Qi; Ikenoue, Tsuneo et al. (2012) A critical role for Rictor in T lymphopoiesis. J Immunol 189:1850-7
Wu, Qi; Liu, Yu; Chen, Chong et al. (2011) The tuberous sclerosis complex-mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. J Immunol 187:1106-12
Wang, Yin; Liu, Yan; Malek, Sami N et al. (2011) Targeting HIF1? eliminates cancer stem cells in hematological malignancies. Cell Stem Cell 8:399-411
Chen, Guo-Yun; Chen, Xi; King, Samantha et al. (2011) Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nat Biotechnol 29:428-35
Liu, Yang; Chen, Guo-Yun; Zheng, Pan (2011) Sialoside-based pattern recognitions discriminating infections from tissue injuries. Curr Opin Immunol 23:41-5
Li, Chi-Shan; Chen, Chong; Zheng, Pan et al. (2010) Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis. PLoS One 5:e13439
Fang, Xianfeng; Zheng, Pan; Tang, Jie et al. (2010) CD24: from A to Z. Cell Mol Immunol 7:100-3
Katoh, Hiroto; Zheng, Pan; Liu, Yang (2010) Signalling through FOXP3 as an X-linked tumor suppressor. Int J Biochem Cell Biol 42:1784-7
Wang, Lizhong; Liu, Runhua; Ribick, Mark et al. (2010) FOXP3 as an X-linked tumor suppressor. Discov Med 10:322-8

Showing the most recent 10 out of 16 publications